Photodynamic therapy with glycoconjugated chlorin photosensitizer
Abstract
Photodynamic therapy (PDT) effectively induces tumor cell apoptosis, but the tumor selectivity and photosensitivity of common photosensitizers, such as aspartyl chlorin (NPe6), are not sufficient. Cancer cells phagocytose glucose 3 to 20 times more efficiently than normal cells; therefore, we examined whether glycoconjugation improves photosensitizer tumor-localizability. HaCaT cells were incubated with H2TFPC (unconjugated chlorin), H2TFPC-SGlc (glycoconjugated chlorin), or NPe6, followed by irradiation with 633 nm LED light (16 J.cm-2). PDT with 1 μM H2TFPC-SGlc for 24 h induced significantly more apoptosis (annexinV+ cells: 74.5%) than PDT with either H2TFPC (2.9%) or NPe6 (0.3%). Based on the IC50, PDT with H2TFPC-SGlc induced tumor cell death more efficiently than NPe6 or H2TFPC in all cell lines examined. The addition of sodium azide, a singlet oxygen quencher, during irradiation significantly suppressed PDT-induced apoptosis in COLO679 cells (-0.4 ± 0.3% → 119 ± 44%), whereas coincubation with deuterium oxide, a singlet oxygen enhancer, enhanced PDT (72 ± 19 → 27 ± 5%). Confocal microscopy revealed that H2TFPC-SGlc accumulated in lysosomes and Golgi bodies, but not in mitochondria or endoplasmic reticulum. In melanoma-bearing mice, intratumoral injection of H2TFPC-SGlc (10-8 mol or 10-9 mol), followed 4 h later by irradiation with 633 nm LED light (150 J.cm-2) controlled tumor growth for 13 consecutive days (10-8 mol). Thus, PDT with H2TFPC-SGlc effectively induces apoptosis in tumor cells via singlet oxygen induction.

Handbook of Porphyrin Science now available in 46 volumes